Reckitt Benckiser Group (LON:RKT) Shares Down 0.5% – Here’s Why
by Scott Moore · The Cerbat GemShares of Reckitt Benckiser Group plc (LON:RKT – Get Free Report) dropped 0.5% during mid-day trading on Tuesday . The stock traded as low as GBX 4,942.60 and last traded at GBX 5,066. Approximately 275,603,125 shares traded hands during trading, an increase of 1,515% from the average daily volume of 17,067,297 shares. The stock had previously closed at GBX 5,094.
Reckitt Benckiser Group News Roundup
Here are the key news stories impacting Reckitt Benckiser Group this week:
- Positive Sentiment: Shares are trading higher intraday, and analysts’ price targets (many at GBX 6,200) remain well above the current price, suggesting analysts still see medium‑term upside relative to today’s level.
- Neutral Sentiment: Royal Bank of Canada reaffirmed a “sector perform” rating and set a GBX 6,200 price target, signaling no change to their view despite recent results. Article Title
- Neutral Sentiment: Citigroup cut its price target from GBX 7,000 to GBX 6,200 but kept a “buy” rating — a mixed signal that trims upside expectations but maintains conviction in recovery potential. Article Title Article Title
- Negative Sentiment: Company results and commentary point to a weak cold & flu season that dented first‑quarter revenues and produced a “slow start” to the year — the primary fundamental reason for recent share weakness. Reckitt Shares Slump as Weak Cold, Flu Season Hits First-quarter Revenue Reckitt Benckiser reports slow start to year after weak cold and flu season
- Negative Sentiment: Near‑term market reaction included intraday selling pressure (reported earlier as a small decline), reflecting investor concern about revenue momentum and near‑term guidance. Trading Down 0.5% – Here’s Why
Wall Street Analyst Weigh In
RKT has been the topic of several analyst reports. Jefferies Financial Group cut their price target on shares of Reckitt Benckiser Group from GBX 5,900 to GBX 5,600 and set a “hold” rating on the stock in a report on Tuesday, March 31st. Berenberg Bank cut their price target on shares of Reckitt Benckiser Group from GBX 5,647 to GBX 5,479 and set a “hold” rating on the stock in a report on Tuesday, March 10th. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a GBX 6,200 price target on shares of Reckitt Benckiser Group in a report on Thursday. Deutsche Bank Aktiengesellschaft cut their price target on shares of Reckitt Benckiser Group from GBX 5,500 to GBX 5,460 and set a “hold” rating on the stock in a report on Wednesday, March 25th. Finally, Citigroup cut their price target on shares of Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating on the stock in a report on Thursday. Two research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, Reckitt Benckiser Group currently has an average rating of “Hold” and a consensus price target of GBX 6,105.57.
Check Out Our Latest Report on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Up 1.4%
The company’s fifty day simple moving average is GBX 5,526.57 and its 200-day simple moving average is GBX 5,812.57. The company has a debt-to-equity ratio of 108.83, a current ratio of 0.85 and a quick ratio of 0.46. The firm has a market capitalization of £30.62 billion, a PE ratio of 9.78, a price-to-earnings-growth ratio of 1.10 and a beta of 0.30.
Reckitt Benckiser Group (LON:RKT – Get Free Report) last announced its quarterly earnings data on Thursday, March 5th. The company reported £122.58 earnings per share for the quarter. Reckitt Benckiser Group had a net margin of 25.23% and a return on equity of 38.45%. On average, analysts forecast that Reckitt Benckiser Group plc will post 331.2110727 EPS for the current year.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.